MAPT and Alzheimer disease: In addition to the biochemical amyloid and tau pathology that are core features of AD, microglia responses, the vascular system, blood–brain barrier, the peripheral immune system, glymphatic and other clearance systems, and potentially the gastrointestinal microbiome influence the clinical progression of the disease [2].